Teclistamab is a medication used to treat multiple myeloma, a type of blood cancer. It works by helping your immune system recognize and fight cancer cells. This medication is designed to target specific proteins found on cancer cells, making it a targeted therapy.

Talquetamab is also a treatment for multiple myeloma. Like teclistamab, it works by engaging your immune system to fight cancer cells. It targets different proteins on the surface of cancer cells to help destroy them.

Daratumumab (often called Dara) is an antibody therapy used in treating multiple myeloma. It works by targeting a specific protein found on myeloma cells, helping the immune system identify and destroy these cancer cells. It’s commonly used in combination with other treatments to improve their effectiveness.

Multiple Myeloma – A blood cancer that develops in plasma cells, which are white blood cells that help fight infection. In this condition, cancerous plasma cells accumulate in the bone marrow and crowd out healthy blood cells. These abnormal cells produce large amounts of defective antibodies, called M proteins, which can cause various complications. The disease often affects multiple bones in the body, leading to weakened bones and potential fractures. Multiple myeloma typically develops gradually, starting from a precancerous condition called monoclonal gammopathy of undetermined significance (MGUS). The disease can cause various symptoms including bone pain, frequent infections, fatigue, and kidney problems.